q&a: how do oncologists approach compound egfr mutations? - targeted therapies in lung cancer 2023
Published 10 months ago • 28 plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
6:39
q&a: how do i handle side effects? - targeted therapies in lung cancer 2023
-
6:04
resistance on targeted therapy: questions patients should ask-targeted therapies in lung cancer 2023
-
4:52
what is palliative care? - targeted therapies in lung cancer 2023
-
7:03
living with advanced cancer: handling uncertainty - targeted therapies in lung cancer 2023
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
1:49
q&a: when should a patient do biomarker retesting? - targeted therapies in lung cancer 2023
-
10:18
treatments and study data for patients with alk nsclc - targeted therapies in lung cancer 2023
-
4:40
tki neoadjuvant: is complete pathological response possible?- targeted therapies in lung cancer 2023
-
3:41
q&a: what can patients do to close the biomarker testing gap?-targeted therapies in lung cancer 2023
-
2:36
the future of local therapy - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
2:37
q&a: what are the platform options for sbrt? - targeted therapies in lung cancer 2023
-
4:04
challenges of targeted kras treatment & current treatments - targeted therapies in lung cancer 2023
-
2:43
nrg1 fusions: treatment options - targeted therapies in lung cancer 2023
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
7:33
q&a: what are the differences in palliative and hospice care?-targeted therapies in lung cancer 2023